UNRESECTABLE OSTEOSARCOMA

Clinical trials for UNRESECTABLE OSTEOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE OSTEOSARCOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for teens fighting relapsed bone cancer

Disease control Ongoing

This study is testing an oral drug called cabozantinib to see if it can control the growth of two aggressive bone cancers, osteosarcoma and Ewing sarcoma, in young patients whose cancer has returned or spread after standard treatment. The drug works by blocking signals tumors nee…

Matched conditions: UNRESECTABLE OSTEOSARCOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

UNRESECTABLE OSTEOSARCOMA

Get alerted when new UNRESECTABLE OSTEOSARCOMA trials appear

New hope for teens fighting relapsed bone cancer